Indivior loses appeal to block generic Suboxone opioid treatments

A divided federal appeals court on Friday ruled against Indivior Plc in its bid to stop Dr. Reddy's Laboratories Ltd and Alvogen from selling generic versions of its opioid addiction treatment Suboxone film that infringed its patents. Reuters Health News

https://en.ojaghia.vet

Leave a Reply

Time limit is exhausted. Please reload CAPTCHA.